Cancers | Free Full-Text | Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells | PLOS ONE
PDF) Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3 | Graham Pawelec - Academia.edu
Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells - ScienceDirect
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines | Cancer Immunology, Immunotherapy
Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma - ScienceDirect
Dendritic Cell-Mediated, DNA-Based Vaccination against Hepatitis C Induces the Multi-Epitope-Specific Response of Humanized, HLA Transgenic Mice | PLOS ONE
Rapid, label-free classification of tumor-reactive T cell killing with quantitative phase microscopy and machine learning | Scientific Reports
Cancers | Free Full-Text | HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target
T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2 - Mimura - 2011 - International Journal of Cancer - Wiley Online Library
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma | eLife
HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance | PNAS
![PDF] Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/27ecd6aea5d720873c6d0a55ae13b24a8ffd6ad3/2-Table2-1.png "PDF] Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29. | Semantic Scholar")
PDF] Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29. | Semantic Scholar
Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1. - Abstract - Europe PMC
Direct identification of HLA-A2/tumor peptide antigen tetramer binding... | Download Scientific Diagram
Binding of Fab CLA12 to melanoma cell lines (A-D) Detection of MART-1... | Download Scientific Diagram
T cells gene-engineered with a gp100/HLA-A2-specific TCR demonstrate... | Download Scientific Diagram
RCSB PDB - 1TVB: Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2
IJMS | Free Full-Text | Molecular Analysis of Elements of Melanoma Insensitivity to TCR-Engineered Adoptive Cell Therapy
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines | Cancer Immunology, Immunotherapy
PDF) Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3 | Graham Pawelec - Academia.edu
Effect of the level of HLA-A2 antigen expression on the recognition of... | Download Scientific Diagram
Assessment of functional reactivity and BV usage by A2/Melan-A... | Download Scientific Diagram
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes | Journal for ImmunoTherapy of Cancer
Interleukin‐2‐induced, melanoma‐specific T cells recognize camel, an unexpected translation product of LAGE‐1 - Aarnoudse - 1999 - International Journal of Cancer - Wiley Online Library
